Myer, N M
Boland, J R
Faraone, S V
Article History
Received: 29 June 2017
Revised: 22 September 2017
Accepted: 10 October 2017
First Online: 12 December 2017
Conflict of Interest
: NMM and JRB were employed by Genomind during the research and authorship of this manuscript. In the past year, SVF received income, potential income, travel expenses, continuing education support and/or research support from Lundbeck, KenPharm, Rhodes, Arbor, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA, Sunovion, Genomind and NeuroLifeSciences. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD.